Industries

Consumer Health & Diagnostics

M&A, financings and valuations for life sciences, clinical and consumer diagnostics, at-home testing, medtech and connected devices, and healthcare communications and consulting.

Start a conversation

Healthcare is where consumer behaviour and clinical evidence meet, and the companies that bridge the two are attracting strategic and private equity buyers. Tully & Holland advises founders and management teams of consumer health, diagnostics and medical device companies, bringing the same senior-led process we have run in consumer markets for three decades.

A diagnostic or device business is valued on its regulatory position, its reimbursement and channel strategy and its clinical data as much as on its financials, and we build the case for a company on all of them. Our healthcare work also covers the services and communications companies that serve the sector.

We advise on sales and divestitures, acquisitions, financings and valuations. Every engagement is led by the senior bankers you meet first.

Consumer Health & Diagnostics transactions

All transactions →
Industry M&A dashboard

Consumer Health & Diagnostics transaction trends

Closed Consumer Health & Diagnostics transactions by year, by quarter and by deal size, drawn from Capital IQ and PitchBook and updated quarterly. Every sector’s dashboard is on the Industries page.

All sectors on the Industries page →

Consumer Health & Diagnostics insights

All Publications →

Questions owners ask

Do you advise early-stage healthcare companies?

We advise companies with revenue and a defined commercial path, including growth-stage businesses raising capital. Our services include private placements and growth financings alongside sales and acquisitions.

Who acquires consumer health and diagnostics companies?

Large diagnostics and medical device strategics, the consumer health divisions of pharmaceutical companies, healthcare-focused private equity groups and, increasingly, consumer companies moving into health and wellness.

How is a diagnostics or medtech company valued?

On a blend of revenue and earnings multiples for commercial businesses, adjusted for regulatory status, growth and the mix of recurring revenue. We benchmark against public comparables and precedent transactions and show the buyer the path to its own return.